Steven Tau
Steven is leveraging metabolic and REDOX vulnerabilities in residual breast cancers cells that remain following anti-estrogen therapy to develop novel therapeutic approaches.
Steven is leveraging metabolic and REDOX vulnerabilities in residual breast cancers cells that remain following anti-estrogen therapy to develop novel therapeutic approaches.